Clinical Trial Update: Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase I study of the monoclonal antibody KRN330 in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• KRN330

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED